Loading candles…
Gem Aromatics Limited, incorporated in October 1997, is an Indian specialty chemicals company that manufactures speciality ingredients such as essential oils, aroma chemicals, value-added derivatives, and advanced intermediates. It serves multiple industries including fragrance and flavor, oral care, cosmetics, pharmaceuticals, nutraceuticals, and personal care. The company is noted as the largest processor of eucalyptus oil in India, holding an estimated 58% market share as of fiscal year 2025. No information on founders, key management, subsidiaries, or stock exchange listings is provided.
This page is a live market overview for GEM AROMATICS LIMITED (GEMAROMA) on the NSE. As a listed security, GEM AROMATICS LIMITED is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for GEMAROMA before placing trades on tick2trade.
As of the latest feed, GEMAROMA last traded at ₹154.76 on NSE, down ₹0.42 (0.27%) from the previous close of ₹155.18. Today's session range is ₹153.66 – ₹156.94, against a 52-week band of ₹133 – ₹274. Traded volume today stands at 6.72K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for GEMAROMA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether GEMAROMA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for GEM AROMATICS LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in GEMAROMA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated GEMAROMA option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Unaudited Results - Q1-FY26 | To consider and approve the unaudited financial results for the quarter ended June 30, 2026 | 13 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 21 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 27 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 13 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended June 30, 2025 | 12 Sep 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.